Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/12/1/81/19478675/12-1-81.pdf
Reference21 articles.
1. Adriamycin (NSC-123 127) in breast cancer An overview of studies;Tormey;Cancer Chemother Rep,1975
2. Survival after first recurrence of breast cancer;Vogel;Cancer,1992
3. Factors predicting for response, time to treatment failure, and survival in women with metastastic breast cancer treated with DAVTH A prospective Eastern Cooperative Oncology Group study;Falkson;J Clin Oncol,1991
4. Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer;Rahman;J Clin Oncol,1997
5. Survival from first recurrence Relative importance of prognostic factors in 1015 breast cancer patients;Clark;J Clin Oncol,1987
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug screening on digital microfluidics for cancer precision medicine;Nature Communications;2024-05-22
2. Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer;JCO Clinical Cancer Informatics;2021-08
3. Targeting SNARE-Mediated Vesicle Transport to Block Invadopodium-Based Cancer Cell Invasion;Frontiers in Oncology;2021-05-21
4. Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer;Breast Cancer Research and Treatment;2021-04-10
5. Prognostic factors for patients with metastatic breast cancer: a literature review;Translational Cancer Research;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3